Table 2.
Seroprotection and seroconversion rates against pandemic H1N1 2009.
| Immunogenicity | Controller | Noncontroller | ||||
|---|---|---|---|---|---|---|
| Baseline proportion (%) | After 1st dose proportion (%) | After 2nd dose proportion (%) | Baseline proportion (%) | After 1st dose proportion (%) | After 2nd dose proportion (%) | |
| Seroprotection | 14/29 (48.3) | 19/29 (65.5) | 21/29 (72.4) | 5/16 (31.3) | 7/16 (43.8) | 8/16 (50.0) |
| Seroconversion | N/A | 13/29 (44.8) | 16/29 (55.2) | N/A | 5/16 (31.3) | 5/16 (31.3) |
Note: N/A: non applicable.